Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05158023 |
|
Recruitment Status :
Completed
First Posted : December 15, 2021
Last Update Posted : April 26, 2024
|
Sponsor:
ASLAN Pharmaceuticals
Information provided by (Responsible Party):
ASLAN Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 13, 2023 |
| Actual Study Completion Date : | September 5, 2023 |
| Certification/Extension First Submitted : | April 17, 2024 |